SCHEMBL9727655

SCHEMBL9727655

COc1ccc(C(=O)c2oc3ccc(O)cc3c2C)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.61
SMN1; SMN2 Q16637 7/20 0.61
KDM4E B2RXH2 7/20 0.61
NPC1 O15118 6/20 0.61
ALDH1A1 P00352 5/20 0.61
RAB9A P51151 5/20 0.61
MEN1 O00255 5/20 0.61
KMT2A Q03164 5/20 0.61
LMNA P02545 1/20 0.61
HSD17B10 Q99714 1/20 0.61
NPSR1 Q6W5P4 1/20 0.55
HPGD P15428 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
TUBB4A P04350 1/20 0.53
TUBB P07437 1/20 0.53
TUBA3C P0DPH7 1/20 0.53
TUBA1B P68363 1/20 0.53
TUBA4A P68366 1/20 0.53
TUBB4B P68371 1/20 0.53
TUBB3 Q13509 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28217436 0.86 NPC1 (0.58) MAPTSMN1; SMN2NPC1ALDH1A1RAB9A
SCHEMBL28209634 0.83 NPC1 (0.64) MAPTSMN1; SMN2KDM4ENPC1ALDH1A1
SCHEMBL716903 0.83 RAB9A (0.74) MAPTSMN1; SMN2KDM4ENPC1ALDH1A1
SCHEMBL11823964 0.82 MAPT (0.73) MAPTSMN1; SMN2KDM4ENPC1ALDH1A1
SCHEMBL9740353 0.82 KDM4E (0.58) MAPTSMN1; SMN2KDM4ENPC1ALDH1A1
SCHEMBL9486652 0.82 HTT (0.64) MAPTSMN1; SMN2KDM4ENPC1ALDH1A1
SCHEMBL9741101 0.80 KDM4E (0.56) MAPTSMN1; SMN2KDM4ENPC1ALDH1A1
Acetic Acid SCHEMBL5511893 0.79 MAPT (0.68) MAPTSMN1; SMN2KDM4ENPC1ALDH1A1
SCHEMBL1287500 0.77 SLC22A12 (0.86) MAPTSMN1; SMN2NPC1MEN1KMT2A
SCHEMBL10460563 0.75 KDM4E (0.47) MAPTSMN1; SMN2KDM4ENPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5091533-A Treating allergies, cardiovascular disorders, inflammation MERCK FROSST CANADA, INC. (CA) 1992-02-25 US disclosed
EP-0447189-A1 5-Hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors MERCK FROSST CANADA INC. (CA) 1991-09-18 EP disclosed